Answers are grounded in this paper and cite their sources.
Our findings show a novel mechanism by which miR-24 promotes hepatic lipid accumulation and hyperlipidemia by repressing Insig1, and suggest the use of miR-24 inhibitor as a potential therapeutic agent for NAFLD and/or atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: